Entry |
|
Name |
Enavogliflozin (INN) |
Formula |
C24H27ClO6
|
Exact mass |
446.1496
|
Mol weight |
446.92
|
Structure |

|
Class |
|
Remark |
|
Efficacy |
Antidiabetic, SGLT-2 inhibitor |
Target |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
A10BK09 Enavogliflozin
D13015 Enavogliflozin (INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01794 SGLT2 inhibitor
D13015 Enavogliflozin
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC5
SLC5A2 (SGLT2)
D13015 Enavogliflozin (INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 31
1 C8y C 15.6100 -17.3600
2 C8y C 15.6100 -18.7600
3 C8y C 16.8000 -19.4600
4 C8y C 18.0600 -18.7600
5 C8y C 18.0600 -17.3600
6 C8x C 16.8000 -16.6600
7 C1b C 19.2500 -16.6600
8 C8y C 20.5100 -17.3600
9 C8x C 20.5100 -18.7600
10 C8x C 21.7000 -19.4600
11 C8y C 22.8900 -18.7600
12 C8x C 22.8900 -17.3600
13 C8x C 21.7000 -16.6600
14 X Cl 19.2500 -19.4600
15 C1y C 24.1500 -19.4600
16 C1y C 14.4200 -16.6600
17 O2x O 14.4200 -15.2600
18 C1y C 13.1600 -14.5600
19 C1y C 11.9700 -15.2600
20 C1y C 11.9700 -16.6600
21 C1y C 13.1600 -17.3600
22 O1a O 13.1600 -18.7600
23 O1a O 10.7800 -14.5600
24 O1a O 10.7800 -17.3600
25 C1b C 13.1600 -13.1600
26 O1a O 14.4200 -12.4600
27 C1x C 14.6300 -19.6700
28 C1x C 15.1200 -21.0000
29 O2x O 16.5200 -20.8600
30 C1x C 25.5500 -19.4600
31 C1x C 24.8500 -20.6500
BOND 35
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 4 14 1
16 11 15 1
17 16 1 1 #Up
18 16 17 1
19 17 18 1
20 18 19 1
21 19 20 1
22 20 21 1
23 16 21 1
24 21 22 1 #Down
25 19 23 1 #Down
26 20 24 1 #Up
27 18 25 1 #Up
28 25 26 1
29 2 27 1
30 27 28 1
31 28 29 1
32 3 29 1
33 15 30 1
34 30 31 1
35 31 15 1
|